[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"non-erosive-gastroesophageal-reflux-disease\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:non-erosive-gastroesophageal-reflux-disease":42},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":4},"100605305",false,"NCT07160790","Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux Disease","Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux(NERD) Disease: Double-blind, Randomized","Inclusion Criteria:\n\n* Subjects who have experienced both heartburn and acid regurgitation\n* Subjects in whom no mucosal breaks were observed on upper GI endoscopy at Visit 1 by LA Classification\n* Subjects who fully understand this clinical trial and voluntarily signed the informed consent form\n\nExclusion Criteria:\n\n* Subjects who have significant gastrointestinal diseases or procedures affecting the esophagus, stomach, or duodenum\n* Subjects who have a history of recent substance abuse, malignancy, systemic autoimmune or immune deficiency diseases, refractory response to PPI\u002FP-CAB, hypersensitivity to study drugs, genetic metabolic disorders, or significant psychiatric conditions.\n* Subjects who showed clinically significant abnormalities in laboratory tests\n* Positive result in the H. pylori test\n* Pregnant or breast-feeding women\n* Subjects who require hospitalization are scheduled to undergo surgery during the study period, or have undergone major surgery requiring general anesthesia\n* Other people deemed unsuitable for participation in this study according to the medical opinion of the investigator","ALL","19 Years","75 Years",{"count":19,"type":20},321,"ESTIMATED","INTERVENTIONAL",[23],"PHASE3","This study aims to evaluate the efficacy and safety of JP-1366 in Patients with NERD",[26],"Non-erosive Gastroesophageal Reflux Disease",[28,29],"Non-erosive Reflux Disease","Non-Erosive Gastro-Esophageal Reflux Disease","NOT_YET_RECRUITING","2025-08-29",{"date":33,"type":34},"2025-09-08","ACTUAL",{"date":36,"type":20},"2025-09-02",{"date":38,"type":20},"2026-06-30",{"name":40,"class":41},"Onconic Therapeutics Inc.","INDUSTRY",""]